C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/18 (2006.01) A61K 31/4375 (2006.01) A61K 31/48 (2006.01) A61P 25/22 (2006.01) C07D 471/22 (2006.01) C07D 498/18 (2006.01) C07D 498/22 (2006.01)
Patent
CA 2591079
A compound having the general structure shown in Formula (I): or pharmaceutically acceptable salts and/or solvates thereof are useful in treating diseases or conditions mediated by NK1 receptors, for example various physiological disorders, symptoms or diseases, including emesis, depression, anxiety and cough.
La présente invention concerne un composé ayant la structure générale présentée dans la formule (I): [La formule chimique doit être insérée ici, car elle apparaît dans l~abrégé sous forme papier] ou des sels et/ou solvates pharmaceutiquement acceptables de celui-ci, qui sont utiles pour traiter des maladies ou pathologies induites par les récepteurs NK1, par exemple divers troubles physiologiques, symptômes ou maladies, y compris le vomissement, la dépression, l~anxiété et la toux.
Chen Xiao
Huang Xianhai
Palani Anandan
Paliwal Sunil
Rao Ashwin U.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
Schering Corporation
LandOfFree
Bridged ring nk1 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bridged ring nk1 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bridged ring nk1 antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1436940